HR Execs on the Move

BroMenn Healthcare System

www.bromenn.org

 
BroMenn Healthcare System is a Normal, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bromenn.org
  • 1304 Franklin Ave
    Normal, IL USA 61761
  • Phone: 309.454.1400

Executives

Name Title Contact Details

Similar Companies

Northeast Kidney Foundation

Over 26 million Americans suffer from chronic kidney disease (CKD), including 1.5 million New Yorkers.  Formed in 1972 as a philanthropic gift of Edwin and Rhoda Sperber, the Foundation provides services to patients, family members, the general public and clinical and academic professionals throughout the Northeast.  The mission of the Northeast Kidney Foundation is to improve the quality of life of those affected by kidney disease and related conditions through early identification, intervention, prevention and support services; to promote organ donation; and to empower those we serve to be an effective voice for better healthcare at the local, state and federal levels.

Health and Medicine Policy Research Group

Health and Medicine Policy Research Group is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

FitRankings

FitRankings is a universal platform for fitness. FitRankings converts all activity from any wearable or fitness app into one measurement unit that is recognized by the CDC (MET Minute). FitRankings is currently focused on re-defining the $10B Corporate Wellness using real-time data from the latest wearable tech and fitness apps. FitRankings Enterprise Solution is used by leading workplaces, Fortune 1000 companies, and government agencies to lower healthcare costs, and keep employees healthy and engaged.

sports therapy and rehabilation Inc

sports therapy and rehabilation Inc is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.